Mitochondrial disease patient motivations and barriers to participate in clinical trials
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mitochondrial disease patient motivations and barriers to participate in clinical trials
Authors
Keywords
Clinical trials, Mitochondrial diseases, Surveys, Adults, Drug research and development, Children, Clinical research design, Patient advocacy
Journal
PLoS One
Volume 13, Issue 5, Pages e0197513
Publisher
Public Library of Science (PLoS)
Online
2018-05-18
DOI
10.1371/journal.pone.0197513
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatable mitochondrial diseases: cofactor metabolism and beyond
- (2016) Felix Distelmaier et al. BRAIN
- “Watching time tick by…”: Decision making for Duchenne muscular dystrophy trials
- (2016) Holly L. Peay et al. Contemporary Clinical Trials
- Nutritional interventions in primary mitochondrial disorders: Developing an evidence base
- (2016) Kathryn M. Camp et al. MOLECULAR GENETICS AND METABOLISM
- The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network
- (2016) Peter A. Merkel et al. Orphanet Journal of Rare Diseases
- Mitochondrial diseases
- (2016) Gráinne S. Gorman et al. Nature Reviews Disease Primers
- Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease
- (2015) Gráinne S. Gorman et al. ANNALS OF NEUROLOGY
- Improving clinical trial design for Duchenne muscular dystrophy
- (2015) Luciano Merlini et al. BMC Neurology
- What can Duchenne Connect teach us about treating Duchenne muscular dystrophy?
- (2015) Richard T. Wang et al. CURRENT OPINION IN NEUROLOGY
- Duchenne muscular dystrophy
- (2015) Perry B. Shieh CURRENT OPINION IN NEUROLOGY
- Moving towards treatments for spinal muscular atrophy: hopes and limits
- (2015) Brunhilde Wirth et al. EXPERT OPINION ON EMERGING DRUGS
- Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards
- (2015) Marina Picillo et al. PARKINSONISM & RELATED DISORDERS
- Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
- (2014) Sumit Parikh et al. GENETICS IN MEDICINE
- The Role of Patient Advocacy Organizations in Shaping Genomic Science
- (2013) Pei P. Koay et al. Annual Review of Genomics and Human Genetics
- Rare Diseases Research
- (2013) Stephen C. Groft CHEST
- Methodology of clinical research in rare diseases: Development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates
- (2013) Elisabeth A. de Blieck et al. Contemporary Clinical Trials
- Mitochondrial Disease
- (2013) Kalliopi Sofou JOURNAL OF CHILD NEUROLOGY
- New treatments for mitochondrial disease—no time to drop our standards
- (2013) Gerald Pfeffer et al. Nature Reviews Neurology
- Review of Clinical Trials for Mitochondrial Disorders: 1997–2012
- (2013) Douglas S. Kerr Neurotherapeutics
- SMA-EUROPE workshop report: opportunities and challenges in developing clinical trials for spinal muscular atrophy in Europe
- (2013) Nathalie Kayadjanian et al. Orphanet Journal of Rare Diseases
- Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling: Report of the ISPOR PRO Good Research Practices for the Assessment of Children and Adolescents Task Force
- (2013) Louis S. Matza et al. VALUE IN HEALTH
- The Rare Diseases Clinical Research Network Contact Registry update: Features and functionality
- (2012) Rachel L. Richesson et al. Contemporary Clinical Trials
- Developing outcome measures for pediatric mitochondrial disorders: Which complaints and limitations are most burdensome to patients and their parents?
- (2012) Saskia Koene et al. MITOCHONDRION
- Molecular Genetic Testing for Mitochondrial Disease: From One Generation to the Next
- (2012) Elizabeth McCormick et al. Neurotherapeutics
- Why are there no proven therapies for genetic mitochondrial diseases?
- (2011) Peter W. Stacpoole MITOCHONDRION
- The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
- (2011) Elizabeth O Lillie et al. Personalized Medicine
- Relationship Between Clinical Outcome Measures and Parent Proxy Reports of Health-Related Quality of Life in Ambulatory Children With Duchenne Muscular Dystrophy
- (2010) Craig M. McDonald et al. JOURNAL OF CHILD NEUROLOGY
- A modern approach to the treatment of mitochondrial disease
- (2009) Sumit Parikh et al. Current Treatment Options in Neurology
- Treatment of mitochondrial electron transport chain disorders: A review of clinical trials over the past decade
- (2009) Douglas S. Kerr MOLECULAR GENETICS AND METABOLISM
- The mitochondrial cocktail: Rationale for combined nutraceutical therapy in mitochondrial cytopathies☆
- (2008) M.A. Tarnopolsky ADVANCED DRUG DELIVERY REVIEWS
- The in-depth evaluation of suspected mitochondrial disease
- (2008) Richard H. Haas et al. MOLECULAR GENETICS AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search